Browsing HV - Institutt for sykepleie og helsefremmende arbeid by Subject "Fatty acids"
Now showing items 1-10 of 10
-
Comparison of bioavailability of krill oil versus fish oil and health effect
(Journal article; Peer reviewed, 2015)Background: The aim of this review is to summarize the effects of krill oil (KO) or fish oil (FO) on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) incorporation in plasma phospholipids or membrane of red blood ... -
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
(Lipids in Health and Disease;19, Article number: 90 (2020), Journal article; Peer reviewed, 2020-05-09)Background: The ever-increasing prevalence of obesity constitutes a major health problem worldwide. A subgroup of obese individuals has been described as “metabolically healthy obese” (MHO). In contrast to metabolically ... -
Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids
(Peer reviewed; Journal article, 2022)Background: Limited evidence suggests that surgical and non-surgical obesity treatment diferentially infuence plasma Lipoprotein (a) [Lp(a)] levels. Further, a novel association between plasma arachidonic acid and Lp(a) ... -
Does dietary fat affect inflammatory markers in overweight and obese individuals? - a review of randomized controlled trials from 2010 to 2016
(Journal article; Peer reviewed, 2017)Background: Obesity, a major cause of death and disability, is increasing worldwide. Obesity is characterized by a chronic, low-grade inflammatory state which is suggested to play a critical role in the development of ... -
Evaluation of a short Food Frequency Questionnaire to assess cardiovascular disease-related diet and lifestyle factors
(Food & Nutrition Research;62(1370), Journal article; Peer reviewed, 2018)BACKGROUND: The Vascular lifestyle-Intervention and Screening in phArmacies (VISA) study investigates diet and lifestyle factors associated with risk of cardiovascular disease (CVD). As part of the study methodology, a ... -
Exchanging a few commercial, regularly consumed food items with improved fat quality reduces total cholesterol and LDL-cholesterol: A double-blind, randomised controlled trial
(Journal article; Peer reviewed, 2016)The healthy Nordic diet has been previously shown to have health bene fi cial effects among subjects at risk of CVD. However, the extent of food changes needed to achieve these effects is less explored. The aim of the ... -
Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health
(Lipids in Health and Disease;19, Article number: 102 (2020), Journal article; Peer reviewed, 2020-05-21)Background: The aim was to investigate if fatty acid profile and estimated desaturase activities; stearoyl CoAdesaturase (SCD), delta-5-desaturase and delta-6-desaturase (D5D; D6D), differ between individuals with metabolically ... -
Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients
(Journal of Oncology;Article ID 254801, Journal article; Peer reviewed, 2012)Fatty acid metabolism is altered in colorectal cancer (CRC). We aimed to investigate incorporation of dietary n-6 and n-3 polyunsaturated fatty acids (PUFAs) into plasma phospholipids (PLs), tumour tissue, and normal ... -
Relationship between fecal content of fatty acids and cyclooxygenase mRNA expression and fatty acid composition in duodenal biopsies, serum lipoproteins, and dietary fat in colectomized familial adenomatous polyposis patients
(Journal article; Peer reviewed, 2010)A few familial adenomatous polyposis studies have focused upon faecal sterols and bile acids but none has analysed the fecal content of fatty acids. We report here findings of an observational study on 29 colectomized ... -
Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP
(Journal article; Peer reviewed, 2010-07)Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but rofecoxib was withdrawn due to cardiovascular side ...